Zosano Pharma Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,250.00
2,861.00
313.00
-
-
764
Cost of Goods Sold (COGS) incl. D&A
1,135.00
3,142.00
2,452.00
2,543.00
2,553.00
764
Gross Income
3,115.00
281.00
2,139.00
2,543.00
2,553.00
764
SG&A Expense
11,084.00
12,331.00
24,229.00
25,190.00
25,817.00
34,101
EBIT
7,969.00
12,612.00
26,368.00
27,733.00
28,370.00
34,865
Unusual Expense
3,487.00
312.00
495.00
900.00
-
511
Non Operating Income/Expense
-
93.00
-
7.00
7.00
16
Interest Expense
760.00
1,848.00
1,799.00
1,192.00
742.00
379
Pretax Income
5,608.00
14,241.00
28,427.00
29,832.00
29,105.00
35,358
Consolidated Net Income
5,608.00
14,241.00
28,427.00
29,832.00
29,105.00
35,358
Net Income
5,608.00
14,241.00
28,427.00
29,832.00
29,105.00
35,358
Net Income After Extraordinaries
5,608.00
14,241.00
28,427.00
29,832.00
29,105.00
35,358
Net Income Available to Common
5,608.00
14,241.00
28,427.00
29,832.00
29,105.00
35,358
EPS (Basic)
9.40
23.80
49.80
43.40
16.82
3.74
Basic Shares Outstanding
596.60
596.60
570.70
688.70
1,730.00
9,452.50
EPS (Diluted)
9.40
23.87
49.81
43.32
16.82
3.74
Diluted Shares Outstanding
596.60
596.60
570.70
688.70
1,730.00
9,452.50
EBITDA
7,541.00
9,570.00
23,916.00
25,190.00
25,817.00
34,101
Non-Operating Interest Income
-
-
235.00
-
-
381
Equity in Affiliates (Pretax)
366.00
-
-
-
-
-
About Zosano Pharma
View Profile
